✉news HealthHealth first seen 4 h ago, last 47 min ago, peak #11
AAOpt 2026 to examine GLP-1 drugs and eye health
Original: AAOpt 2026: GLP-1RAs and ocular health
The American Academy of Optometry's 2026 meeting will feature discussions on GLP-1 receptor agonists and ocular health, examining how widely used weight-loss and diabetes medications may affect patients' eyes. Eye care professionals are expected to review emerging evidence on potential ocular side effects and clinical considerations as prescriptions for drugs like semaglutide continue to grow.
Why now: GLP-1 receptor agonists are being used at unprecedented scale, and clinicians want clarity on their ocular effects.
American Academy of OptometryGLP-1 receptor agonists
Rank over time, top of the chart is #1. 4 snapshots from 4 h ago to 47 min ago.
Evidence
- AAOpt 2026: GLP-1RAs and ocular health · Optometry Times
API: https://socialmediatrends-api.osmike.com/v1/trends/902046